JAK2 and cyclic hematopoiesis: These results indicate that LBPE could downregulate the JAK2/STAT3 signaling pathway to ameliorate ISO-induced CH in H9c2 cells, which also further validates the target role of JAK2 for the therapeutic effects of LBPE against CH.